Crinetics pharmaceuticals announces may 2025 inducement grants under nasdaq listing rule 5635(c)(4)

San diego, may 12, 2025 (globe newswire) -- crinetics pharmaceuticals, inc. (nasdaq: crnx) today announced that on may 10, 2025, the compensation committee of the board of directors granted non-qualified stock option awards to purchase an aggregate of 152,475 shares of its common stock and granted an aggregate of 101,800 restricted stock unit (“rsu”) awards to 35 new non-executive employees, in each case, under the crinetics pharmaceuticals, inc. 2021 employment inducement incentive award plan (the “2021 inducement plan”). the stock options and rsus were granted as inducements material to the employees entering into employment with crinetics in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking